Streetbeat News

Price Targets

EXPE

Benchmark analyst Daniel Kurnos maintains a Buy rating on Expedia Group (NASDAQ:EXPE) and raises the price target from $160 to $180, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 7:14 pm

FDMT

REGN

4D Molecular Therapeutics (NASDAQ:FDMT) released positive Phase 2 data for 4D-150 in wet AMD, meeting investor expectations. BMO Capital Markets raised the target price to $70 from $50, maintaining an Outperform rating and naming FDMT a top pick for early 2024. The data suggests 4D-150's superiority over Regeneron's (NASDAQ:REGN) Eylea in safety and efficacy. FDMT is exploring partnerships for 4D-150's development outside the U.S., with rapid trial enrollment expected to accelerate the development timeline. FDMT shares dropped 6.6% to $30.15.

Portfolio Pulse from Vandana Singh

February 06, 2024 | 7:05 pm

NEXA

JP Morgan analyst Rodolfo Angele maintains a Neutral rating on Nexa Resources (NEXA) and raises the price target from $6 to $7.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 7:05 pm

IDXX

IDEXX Laboratories (NASDAQ:IDXX) has received mixed analyst ratings over the past three months, with a shift towards more bullish sentiment in the last 30 days. Analysts have raised their 12-month price targets, indicating an average target of $615.0, an 8.21% increase from the previous average. The company's financial performance shows strong revenue growth, net margin, ROE, and ROA, but it faces challenges with a high debt-to-equity ratio. IDXX develops and distributes diagnostic products for pets and livestock, with significant revenue from outside the U.S.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 7:00 pm

PLUG

Over the last three months, 25 financial analysts have provided diverse opinions on Plug Power (NASDAQ:PLUG), with recent ratings showing a shift towards a more cautious stance. The average 12-month price target has been adjusted to $5.14, significantly lower than the previous $8.04, indicating a downward trend in expectations. Analysts' actions, ranging from maintaining to lowering ratings and price targets, reflect changing market conditions and company performance. Plug Power's financials show a mix of positive revenue growth but challenges in net margin, ROE, and ROA, with a sound debt management position.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 7:00 pm

LCII

LCI Industries (NYSE:LCII) has received mixed analyst ratings in the last three months, with a shift towards a more neutral stance in the last 30 days. The average 12-month price target for LCII has decreased by 8.07% to $111.00. The company faces challenges in revenue growth, profitability, and asset utilization, with a notable revenue decline of -15.26% as of September 30, 2023. Despite these challenges, LCI Industries maintains a lower than average debt-to-equity ratio, indicating a healthier balance between debt and equity.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 7:00 pm

IDXX

JP Morgan analyst Chris Schott maintains an Overweight rating on IDEXX Laboratories (NASDAQ:IDXX) and raises the price target from $600 to $630.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 6:59 pm

CAT

JP Morgan analyst Tami Zakaria has maintained an Overweight rating on Caterpillar (NYSE:CAT) and increased the price target from $345 to $385.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 6:56 pm

VRNS

Baird analyst Shrenik Kothari maintains a Neutral rating on Varonis Systems (VRNS) and raises the price target from $45 to $48.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 6:54 pm